FilingSEC EDGAR8-K
Quoin Pharmaceuticals Announces Annual General Meeting Results
· SEC accepted
StageCompleted
Filing content
The company approved the election of directors and changes to executive and non-employee director compensation programs at its annual meeting, including increasing the annual base retainer for non-employee directors to up to $250,000.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…